Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
December-2020 Volume 22 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2020 Volume 22 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss

  • Authors:
    • Yaqian Hu
    • Long Wang
    • Zhuojie Zhao
    • Weiguang Lu
    • Jing Fan
    • Bo Gao
    • Zhuojing Luo
    • Qiang Jie
    • Xiaojuan Shi
    • Liu Yang
  • View Affiliations / Copyright

    Affiliations: Department of Orthopedic Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Department of Orthopaedics, Chinese PLA General Hospital, Beijing 100853, P.R. China, Department of Orthopedic Surgery, Honghui Hospital, College of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi 710049, P.R. China
    Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4716-4724
    |
    Published online on: September 28, 2020
       https://doi.org/10.3892/mmr.2020.11543
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Osteoporosis is a common disorder characterized by decreased bone mineral density (BMD) and increased fracture risk. The current techniques detect real‑time BMD precisely but do not provide adequate information to predict early bone loss. If bone loss could be diagnosed and predicted early, severe osteoporosis and unexpected fractures could be prevented, allowing for an improved quality of life for individuals. In the present study, an ovariectomized rat model of bone loss was established and the serum levels of 78 potential cytokines were determined using a protein array. The BMD of ovariectomized rats was dynamically measured by micro‑CT and the early stage of bone loss was defined at the fourth week after surgery. The expression of several serum protein cytokines was indicated to be altered in the ovariectomized rats during an 8‑week time‑course of bone loss. Linear regression analysis revealed that the serum levels of C‑C motif chemokine ligand 2 (CCL2, also known as monocyte chemoattractant protein 1) and C‑X‑C motif chemokine ligand 1 (CXCL1) were significantly associated with a reduction in BMD. The significance of these two factors in indicating bone mass reduction was further verified by analyzing serum samples from 24 patients with BMD using ELISA and performing a linear regression analysis. The serum levels of CCL2 and CXCL1 were inversely correlated with the bone mass. Therefore, the cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss and may be clinically relevant for the early diagnosis and prevention of osteoporosis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

López Picazo M, Humbert L, Di Gregorio S, González Ballester MA and Del Río Barquero LM: Discrimination of osteoporosis-related vertebral fractures by DXA-derived 3D measurements: A retrospective case-control study. Osteoporosis Int. 30:1099–1110. 2019. View Article : Google Scholar

2 

Gutierrez-Buey G, Restituto P, Botella S, Monreal I, Colina I, Rodríguez-Fraile M, Calleja A and Varo N: Trabecular bone score and bone remodelling markers identify perimenopausal women at high risk of bone loss. Clin Endocrinol (Oxf). 91:391–399. 2019. View Article : Google Scholar : PubMed/NCBI

3 

Wang W, Huang CY, Wang ZP, Xu SS, Qian TY, Chen YD and Wu WG: Serum C-C motif ligand 11/eotaxin-1 may serve as a candidate biomarker for postmenopausal osteoporosis. J Med Biochem. 38:353–360. 2019. View Article : Google Scholar : PubMed/NCBI

4 

Eisenhauer A, Müller M, Heuser A, Kolevica A, Glüer CC, Both M, Laue C, Hehn UV, Kloth S, Shroff R and Schrezenmeir J: Calcium isotope ratios in blood and urine: A new biomarker for the diagnosis of osteoporosis. Bone Rep. 10:1002002019. View Article : Google Scholar : PubMed/NCBI

5 

Huang Y, Xie J and Li E: Comprehensive circular RNA profiling reveals circ_0002060 as a potential diagnostic biomarkers for osteoporosis. J Cell Biochem. 120:15688–15694. 2019. View Article : Google Scholar : PubMed/NCBI

6 

Wang J, Yan D, Zhao A, Hou X, Zheng X, Chen P, Bao Y and Jia W, Hu C, Zhang ZL and Jia W: Discovery of potential biomarkers for osteoporosis using LC-MS/MS metabolomic methods. Osteoporosis Int. 30:1491–1499. 2019. View Article : Google Scholar

7 

Yang C, Ren J, Li B, Jin C, Ma C, Cheng C, Sun Y and Shi X: Identification of gene biomarkers in patients with postmenopausal osteoporosis. Mol Med Rep. 19:1065–1073. 2019.PubMed/NCBI

8 

Haghighizadeh E, Shahrezaee M, Sharifzadeh S and Momeni M: Transforming growth factor-β3 relation with osteoporosis and osteoporotic fractures. J Res Med Sci. 24:462019. View Article : Google Scholar : PubMed/NCBI

9 

Arron JR and Choi Y: Bone versus immune system. Nature. 408:535–536. 2000. View Article : Google Scholar : PubMed/NCBI

10 

Chao TH, Yu HN, Huang CC, Liu WS, Tsai YW and Wu WT: Association of interleukin-1 beta (−511C/T) polymorphisms with osteoporosis in postmenopausal women. Ann Saudi Med. 30:437–441. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Wakabayashi H, Kato S, Nagao N, Miyamura G, Naito Y and Sudo A: Interleukin-6 inhibitor suppresses hyperalgesia without improvement in osteoporosis in a mouse pain model of osteoporosis. Calcified Tissue Int. 104:658–666. 2019. View Article : Google Scholar

12 

Harmer D, Falank C and Reagan MR: Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma. Front Endocrinol (Lausanne). 9:7882018. View Article : Google Scholar : PubMed/NCBI

13 

Kim HJ, Kim HJ, Choi Y, Bae MK, Hwang DS, Shin SH and Lee JY: Zoledronate enhances osteocyte-mediated osteoclast differentiation by IL-6/RANKL axis. Int J Mol Sci. 20:14672019. View Article : Google Scholar

14 

Edwards CJ and Williams E: The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis. Osteoporosis Int. 21:1287–1293. 2010. View Article : Google Scholar

15 

Blumenfeld O, Williams FMK, Valdes A, Hart DJ, Malkin I, Spector TD and Livshits G: Association of interleukin-6 gene polymorphisms with hand osteoarthritis and hand osteoporosis. Cytokine. 69:94–101. 2014. View Article : Google Scholar : PubMed/NCBI

16 

Tousen Y, Matsumoto Y, Nagahata Y, Kobayashi I, Inoue M and Ishimi Y: Resistant starch attenuates bone loss in ovariectomised mice by regulating the intestinal microbiota and bone-marrow inflammation. Nutrients. 11:2972019. View Article : Google Scholar

17 

Kotrych D, Dziedziejko V, Safranow K, Sroczynski T, Staniszewska M, Juzyszyn Z and Pawlik A: TNF-α and IL10 gene polymorphisms in women with postmenopausal osteoporosis. Eur J Obstet Gynecol Reprod Biol. 199:92–95. 2016. View Article : Google Scholar : PubMed/NCBI

18 

Ding Q, Zhou H, Yun B, Zhou L, Zhang N, Yin G and Fan J: Interleukin-13 inhibits expression of cyp27b1 in peripheral CD14+ cells that is correlated with vertebral bone mineral density of patients with ulcerative colitis. J Cell Biochem. 118:376–381. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Yang XW, Wang F, Qin RZ, Zhou QL and Huang HX: Elevated serum CCL4/MIP-1β levels in postmenopausal osteoporosis patients are linked with disease severity. Biomark Med. 13:17–25. 2019. View Article : Google Scholar : PubMed/NCBI

20 

Zheng J, Maerz W, Gergei I, Kleber M, Drechsler C, Wanner C, Brandenburg V, Reppe S, Gautvik KM, Medina-Gomez C, et al: Mendelian randomization analysis reveals a causal influence of circulating sclerostin levels on bone mineral density and fractures. J Bone Miner Res. 34:1824–1836. 2019. View Article : Google Scholar : PubMed/NCBI

21 

Wang W, Wang ZP, Huang CY, Chen YD, Yao WF and Shi BM: The neuropeptide vasoactive intestinal peptide levels in serum are inversely related to disease severity of postmenopausal osteoporosis: A cross-sectional study. Genet Test Mol Bioma. 23:480–486. 2019. View Article : Google Scholar

22 

Vollherbst DF, Otto R, Do T, Kauczor HU, Bendszus M, Sommer CM and Möhlenbruch MA: Imaging artifacts of Onyx and PHIL on conventional CT, cone-beam CT and MRI in an animal model. Interv Neuroradiol. 24:693–701. 2018. View Article : Google Scholar : PubMed/NCBI

23 

Kanehisa M and Goto S: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30. 2000. View Article : Google Scholar : PubMed/NCBI

24 

Kanehisa M, Sato Y, Furumichi M, Morishima K and Tanabe M: New approach for understanding genome variations in KEGG. Nucleic Acids Res. 47(D1): D590–D595. 2019. View Article : Google Scholar : PubMed/NCBI

25 

Kanehisa M: Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28:1947–1951. 2019. View Article : Google Scholar : PubMed/NCBI

26 

Krause K, Sabat R, Witte Händel E, Schulze A, Puhl V, Maurer M and Wolk K: Association of CCL2 with systemic inflammation in Schnitzler syndrome. Br J Dermatol. 180:859–868. 2019. View Article : Google Scholar : PubMed/NCBI

27 

Wang Y, Zhang X, Yang L, Xue J and Hu G: Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer. J Bone Oncol. 11:27–32. 2018. View Article : Google Scholar : PubMed/NCBI

28 

Higashino N, Koma YI, Hosono M, Takase N, Okamoto M, Kodaira H, Nishio M, Shigeoka M, Kakeji Y and Yokozaki H: Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma. Lab Invest. 99:777–792. 2019. View Article : Google Scholar : PubMed/NCBI

29 

Shang Y, Tian L, Chen T, Liu X, Zhang J, Liu D, Wei J, Fang W, Chen Y and Shang D: CXCL1 promotes the proliferation of neural stem cells by stimulating the generation of reactive oxygen species in APP/PS1 mice. Biochem Biophys Res Commun. 515:201–206. 2019. View Article : Google Scholar : PubMed/NCBI

30 

Salinas-Muñoz L, Campos-Fernández R, Olivera-Valle I, Mercader E, Fernandez-Pacheco C, Lasarte S, Pérez-Martín L, Navarro-González MT and Sánchez-Mateos: Estradiol impairs epithelial CXCL1 gradient in the cervix to delay neutrophil transepithelial migration during insemination. J Reprod Immunol. 132:9–15. 2019. View Article : Google Scholar : PubMed/NCBI

31 

Manjavachi MN, Passos GF, Trevisan G, Araújo SB, Pontes JP, Fernandes ES, Costa R and Calixto JB: Spinal blockage of CXCL1 and its receptor CXCR2 inhibits paclitaxel-induced peripheral neuropathy in mice. Neuropharmacology. 151:136–143. 2019. View Article : Google Scholar : PubMed/NCBI

32 

Zhang ZJ, Cao DL, Zhang X, Ji RR and Gao YJ: Chemokine contribution to neuropathic pain: Respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons. Pain. 154:2185–2197. 2013. View Article : Google Scholar : PubMed/NCBI

33 

Huh Y, Ji RR and Chen G: Neuroinflammation, bone marrow stem cells, and chronic pain. Front Immunol. 8:10142017. View Article : Google Scholar : PubMed/NCBI

34 

Natoli R, Fernando N, Madigan M, Chu-Tan JA, Valter K, Provis J and Rutar M: Microglia-derived IL-1β promotes chemokine expression by Müller cells and RPE in focal retinal degeneration. Mol Neurodegener. 12:312017. View Article : Google Scholar : PubMed/NCBI

35 

Smirnov A, Pohlmann S, Nehring M, Ali S, Mann-Nüttel R, Scheu S, Antoni AC, Hansen W, Büettner M, Gardiasch MJ, et al: Sphingosine 1-phosphate- and C-C chemokine receptor 2-dependent activation of CD4+ plasmacytoid dendritic cells in the bone marrow contributes to signs of sepsis-induced immunosuppression. Front Immunol. 8:16222017. View Article : Google Scholar : PubMed/NCBI

36 

Ma Z, Zhao X, Deng M, Huang Z, Wang J, Wu Y, Cui D, Liu Y, Liu R and Ouyang G: Bone marrow mesenchymal stromal cell-derived periostin promotes B-all progression by modulating CCL2 in leukemia cells. Cell Rep. 26:1533–1543.e4. 2019. View Article : Google Scholar : PubMed/NCBI

37 

Hardaway AL, Herroon MK, Rajagurubandara E and Podgorski I: Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer. Clin Exp Metastasis. 32:353–368. 2015. View Article : Google Scholar : PubMed/NCBI

38 

Di Munno O and Ferro F: The effect of biologic agents on bone homeostasis in chronic inflammatory rheumatic diseases. Clin Exp Rheumatol. 37:502–507. 2019.PubMed/NCBI

39 

Lacativa PG and Farias ML: Osteoporosis and inflammation. Arq Bras Endocrinol Metabol. 54:123–132. 2010. View Article : Google Scholar : PubMed/NCBI

40 

Mundy GR: Osteoporosis and inflammation. Nutr Rev. 65:S147–S151. 2007. View Article : Google Scholar : PubMed/NCBI

41 

Babu H, Ambikan AT, Gabriel EE, Svensson Akusjärvi S, Palaniappan AN, Sundaraj V, Mupanni NR, Sperk M, Cheedarla N, Sridhar R, et al: Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy. Front Immunol. 10:19652019. View Article : Google Scholar : PubMed/NCBI

42 

Ke JY, Kliewer KL, Hamad EM, Cole RM, Powell KA, Andridge RR, Straka SR, Yee LD and Belury MA: The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice. Nutr Metab (Lond). 12:12015. View Article : Google Scholar : PubMed/NCBI

43 

Siddiqui JA and Partridge NC: CCL2/Monocyte chemoattractant protein 1 and parathyroid hormone action on bone. Front Endocrinol (Lausanne). 8:492017. View Article : Google Scholar : PubMed/NCBI

44 

Valerio MS, Herbert BA, Basilakos DS, Browne C, Yu H and Kirkwood KL: Critical role of MKP-1 in lipopolysaccharide-induced osteoclast formation through CXCL1 and CXCL2. Cytokine. 71:71–80. 2015. View Article : Google Scholar : PubMed/NCBI

45 

Khan UA, Hashimi SM, Bakr MM, Forwood MR and Morrison NA: CCL2 and CCR2 are essential for the formation of osteoclasts and foreign body giant cells. J Cell Biochem. 117:382–389. 2016. View Article : Google Scholar : PubMed/NCBI

46 

Chen W, Foo SS, Taylor A, Lulla A, Merits A, Hueston L, Forwood MR, Walsh NC, Sims NA, Herrero LJ and Mahalingam S: Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection. J Virol. 89:581–593. 2015. View Article : Google Scholar : PubMed/NCBI

47 

Ho-Le TP, Center JR, Eisman JA, Nguyen HT and Nguyen TV: Prediction of bone mineral density and fragility fracture by genetic profiling. J Bone Miner Res. 32:285–293. 2017. View Article : Google Scholar : PubMed/NCBI

48 

Ho-Le TP, Pham HM, Center JR, Eisman JA, Nguyen HT and Nguyen TV: Prediction of changes in bone mineral density in the elderly: Contribution of ‘osteogenomic profile’. Arch Osteoporos. 13:682018. View Article : Google Scholar : PubMed/NCBI

49 

Orwoll ES, Lapidus J, Wang PY, Vandenput L, Hoffman A, Fink HA, Laughlin GA, Nethander M, Ljunggren Ö, Kindmark A, et al: The limited clinical utility of testosterone, estradiol, and sex hormone binding globulin measurements in the prediction of fracture risk and bone loss in older men. J Bone Miner Res. 32:633–640. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hu Y, Wang L, Zhao Z, Lu W, Fan J, Gao B, Luo Z, Jie Q, Shi X, Yang L, Yang L, et al: Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss. Mol Med Rep 22: 4716-4724, 2020.
APA
Hu, Y., Wang, L., Zhao, Z., Lu, W., Fan, J., Gao, B. ... Yang, L. (2020). Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss. Molecular Medicine Reports, 22, 4716-4724. https://doi.org/10.3892/mmr.2020.11543
MLA
Hu, Y., Wang, L., Zhao, Z., Lu, W., Fan, J., Gao, B., Luo, Z., Jie, Q., Shi, X., Yang, L."Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss". Molecular Medicine Reports 22.6 (2020): 4716-4724.
Chicago
Hu, Y., Wang, L., Zhao, Z., Lu, W., Fan, J., Gao, B., Luo, Z., Jie, Q., Shi, X., Yang, L."Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss". Molecular Medicine Reports 22, no. 6 (2020): 4716-4724. https://doi.org/10.3892/mmr.2020.11543
Copy and paste a formatted citation
x
Spandidos Publications style
Hu Y, Wang L, Zhao Z, Lu W, Fan J, Gao B, Luo Z, Jie Q, Shi X, Yang L, Yang L, et al: Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss. Mol Med Rep 22: 4716-4724, 2020.
APA
Hu, Y., Wang, L., Zhao, Z., Lu, W., Fan, J., Gao, B. ... Yang, L. (2020). Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss. Molecular Medicine Reports, 22, 4716-4724. https://doi.org/10.3892/mmr.2020.11543
MLA
Hu, Y., Wang, L., Zhao, Z., Lu, W., Fan, J., Gao, B., Luo, Z., Jie, Q., Shi, X., Yang, L."Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss". Molecular Medicine Reports 22.6 (2020): 4716-4724.
Chicago
Hu, Y., Wang, L., Zhao, Z., Lu, W., Fan, J., Gao, B., Luo, Z., Jie, Q., Shi, X., Yang, L."Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss". Molecular Medicine Reports 22, no. 6 (2020): 4716-4724. https://doi.org/10.3892/mmr.2020.11543
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team